Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Trillium Therapeutics Inc. (TRIL)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
18.440.00 (0.00%)
At close: 04:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close18.44
Open17.92
Bid0.00 x 39400
Ask0.00 x 28000
Day's Range17.83 - 18.49
52 Week Range5.80 - 19.06
Volume0
Avg. Volume1,837,086
Market Cap1.902B
Beta (5Y Monthly)1.76
PE Ratio (TTM)N/A
EPS (TTM)-0.57
Earnings DateNov 15, 2021 - Nov 19, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.02
  • GlobeNewswire

    Trillium Therapeutics Receives Final Court Order Approving Arrangement

    CAMBRIDGE, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, is pleased to announce that it has received a final order from the Supreme Court of British Columbia approving the previously announced plan of arrangement (the “Arrangement”) with PF Argentum ULC (“PF Argentum”), a wholly-owned, indirect subsidiary of Pfizer Inc. (NYS

  • GlobeNewswire

    Trillium Securityholders Approve Acquisition by Pfizer

    CAMBRIDGE, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that its securityholders approved a statutory arrangement with PF Argentum ULC (“PF Argentum”) a wholly-owned, indirect subsidiary of Pfizer Inc. (NYSE: PFE) (“Pfizer”) at the special meeting of Trillium securityholders today. Pursuant to the arrangemen

  • Insider Monkey

    Is Trillium Therapeutics Inc. (TRIL) A Good Stock To Buy?

    Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their quarterly 13F filings. The stocks that are heavily bought by hedge funds historically outperformed the market, though there is no shortage of high profile […]

Advertisement
Advertisement